Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (2) Autor Grinsztejn,Beatriz (2) Veloso,Valdiléa G. (2) Buchbinder,Susan (1) Cardoso,Sandra W. (1) Coelho,Lara E. (1) Fernandes,Nilo Martinez (1) Ferreira,Ana Cristina G. (1) Grinsztejn,Eduarda (1) Guimarães,Monick L. (1) Jesus,Carlos S. de (1) Lippman,Sheri A. (1) Sullivan,Patrick S. (1) Terto,Veriano (1) Mais... Palavra-chave Antiretroviral therapy (1) Brazil (1) HIV (1) HIV testing (1) Home-based testing (1) Infection (1) MSM (1) Primary resistance (1) Self-testing (1) Transmission (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 2017 (1) 2014 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última Transmitted drug resistance in patients with acute/recent HIV infection in Brazil BJID Ferreira,Ana Cristina G.; Coelho,Lara E.; Grinsztejn,Eduarda; Jesus,Carlos S. de; Guimarães,Monick L.; Veloso,Valdiléa G.; Grinsztejn,Beatriz; Cardoso,Sandra W.. Abstract Introduction: The widespread use of antiretroviral therapy increased the transmission of antiretroviral resistant HIV strains. Antiretroviral therapy initiation during acute/recent HIV infection limits HIV reservoirs and improves immune response in HIV infected individuals. Transmitted drug resistance may jeopardize the early goals of early antiretroviral treatment among acute/recent HIV infected patients. Methods: Patients with acute/recent HIV infection who underwent resistance test before antiretroviral treatment initiation were included in this analysis. HIV-1 sequences were obtained using an in house protease/reverse transcriptase genotyping assay. Transmitted drug resistance was identified according to the Stanford HIV Database for... Tipo: Info:eu-repo/semantics/article Palavras-chave: HIV; Infection; Transmission; Primary resistance; Antiretroviral therapy. Ano: 2017 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000400396 Over-the-counter human immunodeficiency virus self-test kits: time to explore their use for men who have sex with men in Brazil BJID Lippman,Sheri A.; Veloso,Valdiléa G.; Buchbinder,Susan; Fernandes,Nilo Martinez; Terto,Veriano; Sullivan,Patrick S.; Grinsztejn,Beatriz. Increasing access and frequency of human immunodeficiency virus testing are critical to stemming the epidemic. In Brazil's concentrated epidemic, human immunodeficiency virus prevalence in the men who have sex with men/transgender population far exceeds that in the general population, but testing rates fall below what is needed to ensure early detection and treatment. Over-the-counter human immunodeficiency virus self-testing kits, now available in stores in the U.S., have enormous potential to increase testing access and frequency and to facilitate early detection and treatment. With the advent of human immunodeficiency virus self-testing upon us, it is timely to engage the scientific community, government, and civil society in a dialog around how to best... Tipo: Info:eu-repo/semantics/article Palavras-chave: Brazil; HIV testing; MSM; Self-testing; Home-based testing. Ano: 2014 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702014000300239 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco